NL-OMON29203
Other
不适用
Comparing tumour heterogeneity in primary tumour, circulating tumour cells and metastases
niversity Medical Centre Groningen0 个研究点目标入组 30 人待定
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- SCLC niet kleincellig longcarcinoom, longkankerlungcancer, tumour heterogeneity, tumor heterogeniteit, CTC, circulating tumour cell, circulerende tumor cel
- 发起方
- niversity Medical Centre Groningen
- 入组人数
- 30
- 状态
- Other
- 最后更新
- 去年
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •1\.Patients with a histologically/cytologically proven pulmonary malignancy.
- •2\.Patients have to have a non\-curable disease state, without curative treatment options
排除标准
- •1\.No growth factor medication
结局指标
主要结局
未指定
相似试验
尚未招募
不适用
Comparing tumour heterogeneity in primary tumour, circulating tumour cells and its metastaseslungcancer1002765510029107NL-OMON45251niversitair Medisch Centrum Groningen50
招募中
不适用
Characterisation of tumour heterogeneity and identification of adaptive resistance mechanisms of metastatic castration-resistant prostate carcinomaC61Malignant neoplasm of prostateDRKS00028021Klinik für Nuklearmedizin am Universitätsklinikum Augsburg45
尚未招募
1/2 期
Tumour heterogeneity studies based on dedicated breast PET using proliferation radiotracers: early detection of the treatment response.2024-512152-38-00Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela100
尚未招募
不适用
Fluorodeoxyglucose (FDG) and human epidermal growth factor receptor 2 (HER2) positron emission tomography (PET) scan in breast cancerBreast cancerCancer - BreastACTRN12624000918527Fiona Stanley Hospital10
招募中
不适用
Value of 7 Tesla in gliomasHigh grade and low grade gliomaNL-OMON24352Medical Delta25